GPT and COVID-19: Another study was conducted in China on 2,922 patients and found that 48.6% of COVID-19 patients developed abnormal liver profiles: high ALT in 22.7%, AST in 7.6%, ALP in 4.6%, and GGTP in 18.5% [16].